4521.T

Kaken Pharmaceutical Co., Ltd. [4521.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

4521.T Stock Summary

Top 10 Correlated ETFs

4521.T


Top 10 Correlated Stocks

4521.T


In the News

4521.T Financial details

Company Rating
Strong Buy
Market Cap
137.49B
Income
8.45B
Revenue
73.9B
Book val./share
3657.83
Cash/share
1841.83
Dividend
150
Dividend %
4.09%
Employees
1.16K
Optionable
No
Shortable
Yes
Earnings
01 Aug 2023
P/E
16.63
Forward P/E
-
PEG
-4.6
P/S
1.86
P/B
1
P/C
1.99
P/FCF
-
Quick Ratio
3.63
Current Ratio
5.85
Debt / Equity
0.03
LT Debt / Equity
-
-
-
EPS (TTM)
221.66
EPS next Y
-
EPS next Q
-
EPS this Y
-27.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.78%
Revenue last 5Y
-5.03%
Revenue Q/Q
0.71%
EPS Q/Q
4.19%
-
-
-
-
SMA20
-4.13%
SMA50
-3.29%
SMA100
-3.36%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.13%
Gross Margin
54%
Oper. Margin
26%
Profit Margin
11%
Payout
-
Shs Outstand
37.47M
Shs Float
33.71M
-
-
-
-
Target Price
-
52W Range
3485.0-4075.0
52W High
-9.89%
52W Low
+5.37%
RSI
52.49
Rel Volume
1.6
Avg Volume
82.71K
Volume
132.7K
Perf Week
4.91%
Perf Month
-1.69%
Perf Quarter
-6.45%
Perf Half Y
-4.87%
-
-
-
-
Beta
0.317601
-
-
Volatility
52.13%, 87.38%
Prev Close
1.46%
Price
3672
Change
1.07%

4521.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-03-31

Metric History 2018-03-312019-03-312020-03-312021-03-31 2022-03-31
Revenue per share
2.43K2.36K2.28K1.94K2K
Net income per share
470.55445.78494.89347.37251.44
Operating cash flow per share
536.27529.89701.79372.64351.15
Free cash flow per share
489.62476.53645.53313.4265.39
Cash per share
1.3K1.47K1.87K2K1.96K
Book value per share
2.81K3.04K3.28K3.53K3.63K
Tangible book value per share
2.81K3.04K3.28K3.53K3.43K
Share holders equity per share
2.81K3.04K3.28K3.53K3.63K
Interest debt per share
96.1597.6198.8100.21101.82
Market cap
254.15B204.15B196.87B167.29B147.73B
Enterprise value
212.93B161.07B141B107.43B90.56B
P/E ratio
13.3511.4910.1612.4815.47
Price to sales ratio
2.582.172.212.231.94
POCF ratio
11.719.667.1711.6311.08
PFCF ratio
12.8310.747.7913.8314.66
P/B Ratio
2.231.691.531.231.07
PTB ratio
2.231.691.531.231.07
EV to sales
2.161.711.581.431.19
Enterprise value over EBITDA
7.145.954.825.234.52
EV to operating cash flow
9.817.625.137.476.79
EV to free cash flow
10.758.485.588.888.98
Earnings yield
0.070.090.10.080.06
Free cash flow yield
0.080.090.130.070.07
Debt to equity
0.030.030.030.030.03
Debt to assets
0.030.020.020.020.02
Net debt to EBITDA
-1.38-1.59-1.91-2.91-2.85
Current ratio
3.353.7655.345.81
Interest coverage
1.72K1.45K1.56K1.05K1K
Income quality
1.141.191.030.770.96
Dividend Yield
0.020.030.030.030.04
Payout ratio
0.320.340.30.430.6
Sales general and administrative to revenue
00000
Research and developement to revenue
0.080.110.070.090.11
Intangibles to total assets
00000.05
Capex to operating cash flow
-0.09-0.1-0.08-0.16-0.24
Capex to revenue
-0.02-0.02-0.02-0.03-0.04
Capex to depreciation
-0.89-0.99-0.95-0.99-1.31
Stock based compensation to revenue
00000
Graham number
5.46K5.52K6.05K5.25K4.53K
ROIC
0.380.340.630.460.31
Return on tangible assets
0.120.110.120.080.06
Graham Net
555.36766.41.28K1.5K1.45K
Working capital
73.65B76.15B86.68B92.39B91.56B
Tangible asset value
113.87B121.13B128.05B135.63B130.09B
Net current asset value
66.51B68.88B78.93B86.59B83.76B
Invested capital
0.030.030.030.030.03
Average receivables
00000
Average payables
11.03B11.47B9.22B8.07B7.14B
Average inventory
16.57B15.19B13B13.74B15.09B
Days sales outstanding
00000
Days payables outstanding
105.0597.0172.7190.2562.08
Days of inventory on hand
143.32124.05115.6162.79158.68
Receivables turnover
00000
Payables turnover
3.473.765.024.045.88
Inventory turnover
2.552.943.162.242.3
ROE
0.170.150.150.10.07
Capex per share
-46.65-53.37-56.26-59.24-85.76

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q3

Metric History 2021-12-312022-03-312022-06-302022-09-30 2022-12-31
Revenue per share
525.22478.39475.02486.11489.56
Net income per share
91.99-18.1975.8879.883.14
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
1.75K1.95K1.92K1.97K1.84K
Book value per share
3.63K3.6K3.58K3.65K3.66K
Tangible book value per share
3.47K3.4K3.38K3.45K3.45K
Share holders equity per share
3.63K3.6K3.58K3.65K3.66K
Interest debt per share
100.61100.63100.61100.61100.61
Market cap
161.28B149.02B146.15B146.15B149.02B
Enterprise value
111.76B91.84B90B89.23B97.01B
P/E ratio
11.44-53.4512.5711.9511.7
Price to sales ratio
8.028.138.037.857.95
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
1.161.081.061.051.06
PTB ratio
1.161.081.061.051.06
EV to sales
5.555.014.954.795.17
Enterprise value over EBITDA
22.2428.4820.7621.121.92
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
0.0200.020.020.02
Free cash flow yield
00000
Debt to equity
0.030.030.030.030.03
Debt to assets
0.020.020.020.020.02
Net debt to EBITDA
-9.85-17.73-12.95-13.46-11.75
Current ratio
5.055.815.75.885.85
Interest coverage
1.21K1.39K1.01K1.04K1.05K
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.10.130.110.120.11
Intangibles to total assets
0.040.050.050.050.05
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
2.74K1.21K2.47K2.56K2.62K
ROIC
0.060.230.080.080.06
Return on tangible assets
0.0200.020.020.02
Graham Net
1.24K1.44K1.42K1.48K1.35K
Working capital
89.45B91.56B91.32B93.79B94.08B
Tangible asset value
133.09B130.09B129.58B132.09B132.23B
Net current asset value
83.53B83.76B83.51B86.1B86.43B
Invested capital
0.030.030.030.030.03
Average receivables
00000
Average payables
7.48B6.87B6.21B6.61B7.1B
Average inventory
17.05B15.95B15.35B15.94B16.49B
Days sales outstanding
00000
Days payables outstanding
77.9760.1572.3472.3979.24
Days of inventory on hand
167.31153.75173.47175.7176.49
Receivables turnover
00000
Payables turnover
1.151.51.241.241.14
Inventory turnover
0.540.590.520.510.51
ROE
0.03-0.010.020.020.02
Capex per share
00000

4521.T Frequently Asked Questions

What is Kaken Pharmaceutical Co., Ltd. stock symbol ?

Kaken Pharmaceutical Co., Ltd. is a JP stock and trading under the symbol 4521.T

What is Kaken Pharmaceutical Co., Ltd. stock quote today ?

Kaken Pharmaceutical Co., Ltd. stock price is $3672 today.

Is Kaken Pharmaceutical Co., Ltd. stock public?

Yes, Kaken Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap